Showing results (1-10 of 47) with videos related to

Sort By:
Pageof 5
British Journal of Haematology|April 7, 2009
Replicative potential of human natural killer cellsHiroyuki Fujisaki, Harumi Kakuda, Chihaya Imai, et al.
Pediatric Blood & Cancer|August 9, 2019
Double-conditioning regimen consisting of high-dose thiotepa and melphalan with autologous stem cell rescue for high-risk pediatric solid tumors: A second reportKeiko Okada, Kai Yamasaki, Chika Nitani, et al.
Japanese Journal of Clinical Oncology|September 5, 2013
Phase I study of bevacizumab plus irinotecan in pediatric patients with recurrent/refractory solid tumorsKeiko Okada, Kai Yamasaki, Chika Tanaka, et al.
Cancer Medicine|June 7, 2016
Sorafenib treatment in children with relapsed and refractory neuroblastoma: an experience of four casesKeiko Okada, Yoshiko Nakano, Kai Yamasaki, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|February 5, 2014
[Single institution experience of HLA-haploidentical hematopoietic stem cell transplantation for children: current problems and perspective]Keiko Okada, Yoshiko Nakano, Kai Yamasaki, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|March 28, 2012
[Successful treatment for thrombotic microangiopathy with recombinant human soluble thrombomodulin after umbilical cord blood transplantation]Keiko Okada, Asako Horino, Kai Yamasaki, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 15, 2010
Cytotoxicity of activated natural killer cells against pediatric solid tumorsDuck Cho, David R Shook, Noriko Shimasaki, et al.
Neurology International|April 30, 2021
Tumor-Treating Fields Therapy for Pediatric Brain TumorsAtsushi Makimoto, Ryo Nishikawa, Keita Terashima, et al.
Cytotherapy|March 31, 2012
A clinically adaptable method to enhance the cytotoxicity of natural killer cells against B-cell malignanciesNoriko Shimasaki, Hiroyuki Fujisaki, Duck Cho, et al.
Fujita Medical Journal|February 5, 2026
Usefulness of cell-free and concentrated pleural effusion reinfusion therapy in terminal cancer patientsHiroyuki Fujisaki, Masanobu Usui, Akihiro Ito, et al.
Pageof 5